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Abstract
Introduction: C-reactive protein (CRP) has been shown to be a valuable marker in the diagnosis of infection and
in monitoring its response to antibiotics. Our objective was to evaluate serial CRP measurements after prescription
of antibiotics to describe the clinical course of Community-Acquired Sepsis admitted to intensive care units (ICU).
Methods: During a 12-month period a multi-center, prospective, observational study was conducted, segregating
adults with Community-Acquired Sepsis. Patients were followed-up during the first five ICU days, day of ICU
discharge or death and hospital outcome. CRP-ratio was calculated in relation to Day 1 CRP concentration. Patients
were classified according to the pattern of CRP-ratio response to antibiotics: fast response if Day 5 CRP-ratio was <
0.4, slow response if Day 5 CRP-ratio was between 0.4 and 0.8, and no response if Day 5 CRP-ratio was > 0.8.
Comparison between survivors and non-survivors was performed.
Results: A total of 891 patients (age 60 ± 17 yrs, hospital mortality 38%) were studied. There were no significant
differences between the CRP of survivors and non-survivors until Day 2 of antibiotic therapy. On the following
three days, CRP of survivors was significantly lower (P < 0.001). After adjusting for the Simplified Acute Physiology
Score II and severity of sepsis, the CRP course was significantly associated with mortality (ORCRP-ratio = 1.03,
confidence interval 95%= (1.02, 1.04), P < 0.001). The hospital mortality of patients with fast response, slow response
and no response patterns was 23%, 30% and 41%, respectively (P = 0.001). No responders had a significant
increase on the odds of death (OR = 2.5, CI95% = (1.6, 4.0), P < 0.001) when compared with fast responders.
Conclusions: Daily CRP measurements after antibiotic prescription were useful as early as Day 3 in identification of
Community-Acquired Sepsis patients with poor outcome. The rate of CRP decline during the first five ICU days was
markedly associated with prognosis. The identification of the pattern of CRP-ratio response was useful in the
recognition of the individual clinical course.
Introduction
Sepsis is a complex clinical syndrome that complicates
severe infection and is characterized by systemic inflam-
mation and widespread organ dysfunction [1,2]. Tradi-
tional clinical signs of sepsis, such as fever, tachycardia,
tachypnea and leukocytosis, are quite sensitive but
poorly specific of infection, occurring in a variety of
non-infectious conditions [3,4].
In most cases, the assessment of infection response to
antibiotics relies mostly on the evolution of the same cri-
teria used for diagnosis [5-7]. Microbiological criteria are
also of little help in the assessment of response, because of
the time needed to obtain culture results, the interference
of antibiotics on bacterial growth in vitro and possible dif-
ficulties in recollecting some microbiological samples.
These areas of uncertainty in the clinical decision-mak-
ing process led investigators to look at the inflammatory
cascade for potential objective markers of infection [8,9].
These biomarkers, among which C-reactive protein * Correspondence: povoap@netcabo.pt
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surrogates of infection diagnosis.
It has been shown that a single CRP measurement helps
in the diagnosis of infection [12-14] with some controversy
concerning prognosis [15,16], and that serial determina-
tions are useful in the prediction of infection [17,18] as
well as in monitoring its response to treatment [19-23]. In
addition, it has been described, in ventilator associated
pneumonia (VAP), a good correlation between bacterial
load and CRP levels [24], as well as between the adequacy
of antibiotic therapy and changes of CRP concentration
overtime [19,24-26]. Besides, serial CRP measurements
enable clinicians to identify individual CRP patterns of
response to antibiotic therapy with a good correlation with
the individual clinical course [19,20,23,27]. Finally, a recent
trial, performed in an outpatient setting, clearly demon-
strated that the availability of CRP had a significant impact
on antibiotic prescription [28].
Therefore, further investigation in this area is critical,
assessing the course of biomarkers after prescription of
antibiotic therapy in a larger cohort of infected intensive
care unit (ICU) patients. The aim of the present study was
to evaluate the value of serial CRP measurements after
prescription of antibiotics to describe clinical course in




The SACiUCI study (Sepsis Adquirida na Comunidade e
internada em Unidade de Cuidados Intensivos)w a sap r o -
spective, multiple-center, observational study, designed to
evaluate the epidemiology of CAS. Details of study design,
definitions, data collection and management are provided
elsewhere [29].
Briefly, all patients who were ≥ 18 years old and newly
admitted with CAS to the participating ICU (see Addi-
tional file 1 for a list of the participating ICU) from
December 2004 to November 2005 were consecutively
enrolled. Almost two thirds of the patients with sepsis
were admitted from the emergency room of the hospital
of the participating ICU, and the remaining came from
emergency departments of other hospitals. Patients were
followed-up until death or hospital discharge. Only the
first ICU admission was included. Since this observational
study did not require any deviation from routine medical
practice, Institutional Review Boards approved the study
design and waived the need of informed consent.
Definitions and selection of participants
Infection was defined as a pathologic process caused by
the invasion of normally sterile tissue or fluid or body
cavity by a pathogenic or potentially pathogenic micro-
organism [1] and/or clinically suspected infection, plus
the prescription of antimicrobial therapy. Community-
acquired infection was defined as the onset of infection
prior to hospital admission or not present at admission
but becomes evident in the first 48 hrs [30]. Presence of
sepsis was defined according to the American College of
Chest Physicians/Society of Critical Care Medicine Con-
sensus Conference criteria [31].
The presence of health-care associated infection (HCAI)
was defined at hospital admission according to the pre-
sence of the following criteria: home infusion therapy
(including antibiotics) or home wound care; chronic dialy-
sis or chemotherapy within 30 days; hospitalization for 2
days or more in the preceding 90 days; residence in a nur-
sing home or extended care facility [32,33].
Data collection
Data were collected prospectively either using pre-
printed case report forms, a specific base software or
on-line through the study web page.
Data collection included demographic data and comor-
bid diseases. Clinical and laboratory data at the time of
hospital admission was recorded. The Simplified Acute
Physiology Score (SAPS) II [34] was calculated. Micro-
biological and clinical infectious data were reported. C-
reactive protein, body temperature, white blood cell
count (WBC) and the Sequential Organ Failure Assess-
ment (SOFA) score [35] were evaluated during the first
five days of ICU stay. Blood samples were obtained from
an arterial line at ICU admission and subsequently every
morning.
For purposes of the time dependent analysis Day 1 (D1)
was defined as the day of ICU admission. The following
days were successively named as D2, D3 up to D5.
The withdrawal of the inflammatory stimulus results in
a sharp decrease of the CRP serum concentration in a way
similar to a first-order elimination kinetics [36,37]. Conse-
quently, relative CRP variations are more informative that
absolute changes. As a result we assessed a new variable,
CRP-ratio, which was calculated in relation to D1 CRP
concentration. Subsequently, we classified patients accord-
ing to three patterns of CRP-ratio response to antibiotic
therapy: fast reponse, if D5 CRP value was less than 40%
of D1 value; slow response, if D5 CRP was between 40%
and 80% of D1; and no response, if D5 CRP was higher
than 80% of D1 [10,11,19]. The CRP-ratio patterns were a
modification of others previously published [19,20,27].
The evolution of CRP, CRP-ratio, temperature and
WBC during the five days of CAS course was analyzed
comparing survivors and non-survivors.
Data processing and statistical analysis
Data entry was performed by a single investigator in
each participating center and consistency was assessed
with a rechecking procedure of a 10% random sample of
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detail (see Acknowledgements) for missing information,
implausible and outlying values.
Continuous variables were expressed as means and
standard deviations (SD) or median and interquartile
range (IQR) if the distribution was clearly assymetric.
Comparisons between groups were performed with two-
tailed unpaired Student’s t-test, one-way ANOVA,
Mann-Whitney U or Kruskal-Wallis H tests for continu-
ous variables according to data distribution. Fisher’s
exact test and Chi-square test was used to carry out com-
parisons between categorical variables as appropriate.
For the statistical analysis of the patient’s status at hospi-
tal discharge as function of a longitudinal covariate (five
measurements of CPR) we used a two-step approach. First,
we modeled the CRP measurements as a function of time
(five days of CRP measurement). We used a linear mixed
model that allowed us to predict an intercept and a slope
for each patient. This step is conceptually similar to fitting
a linear regression, Mean_CRP = a + b*day, for each
patient and obtaining an individual intercept (a) and slope
(b) per patient. The intercept describes the initial CRP
value and the slope describes the CPR rate of change per
day for a specific patient. We assumed a normal distribu-
tion of the random effects. Once the model was fitted, the
estimates for the intercepts and slopes were obtained as
the best linear unbiased predictors, BLUPs [38]. Figure 1
shows the observed values of CRP and predicted values by
the model for a randomly selected group of patients.
For the second step, we started by computing the relative
rate of CRP change, CRP-ratio, per day for each patient
which is obtained by dividing the slopes by the intercepts.
This quantity gives the percentage of change per day in
CRP, relative to the first measurement (intercept). Then,
we used the individual CRP-ratios and intercepts, together
with SAPS II and sepsis severity (uncomplicated sepsis,
severe sepsis and septic shock), as covariates in a logistic
regression for hospital mortality. This model allowed us to
compute the odds ratios (OR) associated with the CRP
profile (expressed as an intercept and a rate of change per
day, the CRP-ratio) adjusted for patient’s severity (SAPS II
and sepsis severity). Because the covariates “intercept” and
“CRP-ratio” are estimates and not observed values, the
standard errors provided by the software are not correctly
computed. Thus, we obtained estimated of the correct
standard errors for the regression coefficients through
bootstraping. A similar approach was used for the five days
of measurements of temperature and WBC. However,
WBC was skewed and we used a transformation by taking
the natural log of WBC (log-WBC) to comply with the
normal assumption.
Additionally, we analysed the association between hos-
pital mortality and CRP by considering the patterns of
CRP-ratio response. Only patients with available
measurements at D1 and D5 were considered for this
analysis. We computed the OR of hospital mortality for
the CRP-ratio patterns using a logistic regression and
adjusting for SAPS II and sepsis severity.
For all logistic models, we checked the Hosmer and
Lemeshow goodness-of-fit and computed the receiver
operating characteristic (ROC) curve to evaluate model
discrimination. Data were analyzed using PASW v.18.0
for MAC (SPSS, Chicago, IL, USA) and R (Development
Core Team. R: A Language and Environment for Statis-
tical Computing. Vienna, Austria: 2005). All statistics
were two-tailed and significance level was set at 0.05.
Results
Characteristics of the study population
A total of 891 patients with CAS were included (Table 1);
209 patients were classified as having HCAI. The lungs
were the most common site of infection (61%), followed
by the abdomen (18%) and urinary tract (7%). Cultures
were positive in 40% of the patients, with Streptococcus
pneumoniae (21%), Escherichia coli (18%) and methicillin
sensitive Staphylococcus aureus (12%) the three most com-
mon isolated microorganisms. On ICU admission, 9% of
CAS patients presented with uncomplicated sepsis, 40%
severe sepsis and 51% septic shock. The overall ICU and
hospital mortality rate of CAS was 30% (N = 265) and 38%
(N = 338), respectively.
C-reactive protein as a marker of sepsis resolution
At D1 (Table 1), CRP of survivors and non-survivors was
not statistically different, 19.8 ± 12.5 mg/dL vs. 20.7 ± 12.8
mg/dL (P = 0.367). When we compared CRP (Figure 2) of
survivors and non-survivors at the different time points,
we found that CRP of non-survivors was significantly
higher since D3 onwards (P < 0.001, for D3, D4 and D5).
After adjusting for SAPS II and the severity of sepsis, the
initial value of CRP remained not significantly associated
with hospital mortality (ORinitial = 1.01, confidence interval
(CI)95% = (0.99, 1.02), P = 0.297). On the contrary, the
course of CRP measured as the relative changes during
the first five ICU days, was significantly associated with
hospital mortality (ORCRP-ratio= 1.03, CI95% = (1.02, 1.04),
P < 0.001). For example, a patient with an average
decrease of CRP concentration of 10% per day has 32%
less chances of dying when compared to a patient with the
same SAPS II score and the same severity of sepsis but
with no CRP decrease. The ability of the model to predict
hospital outcome assessed by the area under the ROC
curve was 0.77 (CI95% =( 0 . 7 3 ;0 . 8 0 ) ) .
To assess the impact of the variable HCAI, we added
this variable to our model to study its interaction with the
initial value of CRP and CRP-ratio. The interactions were
not significant (P = 0.579 and P = 0.182, respectively),
indicating that there is no evidence in our patient
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subgroup of septic patients.
The same analysis, restricted to the subgroup of septic
shock patients, presented similar results (data not shown).
Temperature and WBC and resolution of sepsis
At D1, temperature and WBC of survivors and non-sur-
vivors were not statistically different (Table 1), 37.5 ± 1.3°
C vs. 37.5 ± 1.1°C (P = 0.799) and median (IQR) 12.4 (8.5,
18.7) × 10
3/mm
3 vs. 12.4 (6.9, 18.5) × 10
3/mm
3 (P =
0.496), respectively. Time dependent analysis of tempera-
ture from D1 to D5 showed no association between tem-
perature evolution and survival (P = 0.360). Temperature
decreased likewise in survivors and non-survivors. Simi-
larly, no differences were found on the WBC course
along the first five days of the ICU stay (P = 0.594).
Clinical course and sepsis resolution
Sepsis resolution during antibiotic therapy was also
monitored with daily measurements of SOFA score. The
time dependent analysis of SOFA score from D1 to D5
of antibiotic therapy of survivors and nonsurvivors was
significantly different (P < 0.001). In survivors the SOFA
decreased steadily from 6.3 ± 3.3 at D1 to 4.9 ± 3.3 at
D5 whereas in non-survivors it remained roughly
unchanged (D1: 9.1 ± 4.0 and D5: 9.0 ± 4.0).
Patterns of CRP-ratio response to antibiotics
Community-acquired sepsis patients were divided accord-
ing to three patterns of CRP-ratio response to antibiotic
therapy. Two hundred died or were discharged before D5.
One hundred and thirty five patients had no CRP recorded
at D1 or D5. Five hundred, fifty-six patients had complete
data for the analysis. One hundred, ninety-nine (36%)
patients were classified as fast response, 149 (27%) as slow
response and 208 (37%) as no response.
T h eI C Um o r t a l i t yr a t ew a ssignificantly different
according to the patterns of CRP-ratio response: fast
response 14%, slow response 20% and no response 32%
(P < 0.001). After adjusting for SAPS II and severity of
Figure 1 Individual CRP course for a group of patients during the first five ICU days. Dots indicate the individual observed values at the
different time points, from day 1 to day 5, and the dashed lines represent the predictions obtained by a linear mixed model for CRP with
random intercept and random slope for time. The intercept (a) describes the initial CRP value and the slope (b) describes the CRP rate of
change per day for a specific patient (see text for further explanation). CRP, C-reactive protein; ICU, intensive care unit.
Póvoa et al. Critical Care 2011, 15:R169
http://ccforum.com/2011/15/4/R169
Page 4 of 10sepsis, the odds of death for slow or no response
patients were 1.6 (CI95% (0.9, 2.9), P = 0.119) and 3.0
(CI95% (1.8, 5.1), P < 0.001), respectively, when com-
pared with the fast response ones. By D3, median CRP-
ratio (5
th and 95
th percentiles) was 0.81 (0.40, 1.30), 0.95
(0.62, 1.48) and 1.22 (0.70, 6.64) in patients with fast
response, slow response, no response patterns, respec-
tively (P < 0.001).
The hospital mortality was also significantly associated
with the pattern of response (P = 0.001). Fast respon-
ders have lower mortality (23%) when compared with
slow and no responders (30% and 41%, respectively).
After adjusting for SAPS II and severity of sepsis, the
pattern of CRP-ratio response remained significantly
associated with mortality. No responders had a signifi-
cantly increase on the odds of mortality (OR = 2.5,
CI95% = (1.6, 4.0), P < 0.001) when compared with fast
responders. Slow responders showed a non-significant
increase on the odds of mortality in comparison with
the fast responders (OR = 1.5, CI95% = (0.9, 2.5), P =
0.124).
The same analysis, restricted to the subgroup of septic
shock patients, presented similar results (data not
shown).
Association between CRP-ratio patterns of response with
temperature and WBC course
Temperature decreased significantly faster for the fast
and slow response patterns groups when compared with
the no response pattern group (P = 0.004 and P < 0.001,
respectively) (Figure 3). However, the D1 and D5 tem-
perature of patients with the fast and slow response
CRP-ratio patterns was very similar (D1: 37.4 ± 1.1°C
and 37.5 ± 1.0°C and D5: 37.3 ± 0.8°C and 37.5 ± 0.9°C
for fast and slow response, respectively), while the tem-
perature of the patients with no response CRP-ratio pat-
tern increased slightly from 37.6 ± 1.1°C at D1 to 37.8 ±
0.9°C at D5.
O nt h eo t h e rs i d e ,n os i g n i f i c a n tt i m et r e n dw a s
observed regarding WBC for the fast response pattern
(P = 0.137) and no significant differences were found for
the slow and no response pattern groups (P = 0.680 and
P = 0.619, respectively) in comparison to the fast
response group (Figure 3).
Association of CRP-ratio patterns of response with clinical
course
The time dependent analysis of the SOFA score of the
three patterns of CRP-ratio response from D1 to D5
Table 1 Baseline characteristics of community-acquired sepsis patients
Characteristic
a Total Survivors Nonsurvivors P
N = 891 N = 553 N = 338
Age, mean ± SD 60 ± 17 58 ± 18 65 ± 16 < 0.001
Male sex, n (%) 574 (64%) 344 (60%) 230 (40%) 0.071
b
SAPS II, mean ± SD 50 ± 19 44 ± 15 60 ± 20 < 0.001
SOFA, mean ± SD 7.4 ± 3.0 6.3 ± 3.3 9.1 ± 4.0 < 0.001
Mechanical ventilation, n (%) 820 (92%) 487 (88%) 335 (99%) < 0.001
RRT, n (%) 62 (7%) 33 (6%) 30 (9%) 0.043
Primary admission diagnoses, n (%)
Medical non coronary 693 (78%) 423 (61%) 270 (39%) 0.023
Medical coronary 10 (1%) 3 (30%) 7 (70%)
Trauma 38 (4%) 31 (82%) 7 (18%)
Scheduled surgery 4 (< 1%) 2 (50%) 2 (50%)
Emergency surgery 146 (16%) 94 (64%) 52 (36%)
CRP (mg/dl), mean ± SD 20.1 ± 13.9 19.8 ± 12.5 20.7 ± 12.8 0.367
Temperature (°C), mean ± SD 37.5 ± 1.2 37.5 ± 1.3 37.5 ± 1.1 0.799
WBC (×10
3/mm
3), median (IQR) 12.4 (8 to 19) 12.4 (9 to 19) 12.4 (7 to 19) 0.496
ICU LOS, days, median (IQR) 9 (5 to 15) 9 (6 to 14) 8 (3 to 17) < 0.001
c
Hospital LOS, days, median (IQR) 18 (10 to 29) 21 (14 to 31) 11 (4 to 23) < 0.001
c
Severity of sepsis
Uncomplicated sepsis 83 (9%) 67 (81%) 16 (19%) < 0.001
Severe sepsis 358 (40%) 265 (74%) 93 (26%)
Septic shock 450 (51%) 221 (49%) 229 (51%)
a CRP, C-reactive protein; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; NS, not significant; SAPS, Simplified Acute Physiology Score; SD,
standard deviation; SOFA, Sequential Organ Failure Assessment; RRT, renal replacement therapy; WBC, white blood cell count.
b Fisher’s exact test
c Mann-Whitney U test
Póvoa et al. Critical Care 2011, 15:R169
http://ccforum.com/2011/15/4/R169
Page 5 of 10showed that these patterns of evolution were significantly
different (fast vs. slow responders, P = 0.003 and fast vs.
no responders, P < 0.001) (Figure 4). The SOFA scores of
patients with the fast and slow CRP-ratio response pat-
terns decreased from 7.0 ± 3.7 and 6.9 ± 3.4 at D1 to 5.1 ±
3.6 and 5.6 ± 3.9 at D5. Opposed to this were the SOFA
scores of the patients with no response, in which the CRP-
ratio pattern remained almost unchanged, from 6.8 ± 3.3
at D1 to 6.8 ± 3.9 at D5.
Discussion
In the present study, we assessed the course of serum
CRP concentrations in the first five days after prescrip-
tion of antibiotics in a large cohort of CAS patients
admitted to ICU. In survivors, CRP showed a marked
decrease and was significantly lower in comparison to
non-survivors from D3 onwards. Besides, the identifica-
tion of an individual pattern of CRP-ratio response
showed that patients with a no response pattern had
more than three times the odds of dying in the ICU
when compared to patients with a fast response pattern.
Based on our findings, daily CRP measurements can be
used as an early marker of CAS resolution and might be
helpful in the clinical-decision making process, since the
pattern of CRP-ratio response correlates with the indivi-
dual clinical course, improving or worsening, as well as,
the rate of improvement.
T h ec r i t e r i au s e dt oa s s e s si n f e c t i o nr e s p o n s et oa n t i -
biotics [6,7] can be influenced by several non-infectious
factors [19]. Consequently, the reliance on those mar-
kers, not only make the diagnosis of sepsis but also the
evaluation of the response to therapy often misleading.
Even though the Clinical Pulmonary Infection Score
(CPIS) [39] was not designed to monitor VAP response to
antibiotics, Luna et al. [40] studied the performance of
serial CPIS measurements in VAP resolution. In compari-
son with non-survivors, CPIS of survivors was significantly
l o w e ra tD 3a n dD 5 ,b u tn o ta tD 7 .H o w e v e r ,o t h e r sd i d
not reproduce these findings [41].
These limitations led investigators to look at the
inflammatory cascade for potential objective markers of
infection [8]. Many serum markers have been assessed
in sepsis [2,42]; procalcitonin and CRP being the more
extensively studied [11,43].
We have already shown in patients with VAP [19],
bloodstream infections [20] and community-acquired
pneumonia [27], that in survivors CRP decreases in the
first days of antibiotic therapy while in non-survivors it
Figure 2 CRP course during the first five ICU days in survivors and nonsurvivors. Observed means of CRP during the first five days in ICU
stay for survivors (dashed line) and nonsurvivors (solid line) at hospital discharge. Error bars represent point-wise 95% confidence intervals. (*P <
0.001); CRP, C-reactive protein; ICU, intensive care unit.
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reproduced those findings in a much larger cohort of
CAS patients, clearly showing that survivors present an
early decrease in CRP concentration that was signifi-
cantly lower than that of non-survivors, from D3
onwards (P < 0.001). Taking into account data from
other studies [19,23-27], it seems that CRP could be
used as an early marker, as early as D3, of infection
response to antibiotics. Since early CRP changes corre-
late with the adequacy of antibiotic therapy [19,24-26]
and to the bacterial load, at least in VAP patients [24],
it seems that the CRP course could be used as a surro-
gate marker of the clinical course of infection [11].
We have also previously introduced the concept of pat-
terns of CRP-ratio response to antibiotic therapy
[19,20,27]. In the SACiUCI study, with a much larger sam-
ple size, we have reproduced the preliminary findings,
demonstrating that patients with fast and slow response
CRP-ratio patterns had a significantly lower mortality than
those in which CRP-ratio remained elevated.
We went further in our analysis to study the associa-
tion between CRP-ratio patterns of response with the
evolution of the SOFA score. At D1, patients with dif-
ferent patterns of CRP-ratio response showed a similar
SOFA score. However, patients with fast and slow
response patterns showed an almost parallel and signifi-
cant decrease in SOFA score. In contrast, in patients
with no response pattern SOFA score remained almost
unchanged over the study period. This comparable evo-
lution between the CRP-ratio course and SOFA score
was also observed in survivors and non-survivors. In
other words, increasing or persistently high CRP con-
centrations, suggest persistence of inflammatory activity,
and were associated with poor prognosis, whereas
decreasing CRP levels suggests resolution of the inflam-
matory response, and was associated with a better out-
come [15].
Our study has several important strengths. To date, as
far as we are aware, this is the largest multiple-center
study evaluating the course of a biomarker, CRP, over a
period of five days that are the crucial days in which to
assess an infection response. The majority of included
patients were admitted with severe sepsis and septic
shock and all eligible patients were included, without
exclusions, independently of the presence of comorb-
ities, previous antibiotic therapy, underlying diagnosis or
bacteriologic isolates that make our study population
more representative of the current clinical practice.
Figure 3 Temperature and WBC course during the first five ICU days according to CRP-ratio patterns. Mean temperature and WBC count
(log transformed) during the first five days in ICU, according to the different patterns of CRP-ratio response to antibiotics. Error bars represent
point-wise 95% confidence intervals. CRP, C-reactive protein; ICU, intensive care unit; WBC, white blood cell.
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tions. The nonrandomized and observational nature of
the study design bears the potential of unmeasured con-
founders that may have caused differences in therapeutic
and supportive approach, namely initiation of antibiotic
therapy. We studied a mixed group of medical and sur-
gical CAS patients. It is possible that other types of
patients (for example, solid organ transplant recipients,
febrile neutropenia, allogeneic stem cell transplantation)
as well as infections (for example, viral infections) may
have different CRP time-courses. Finally, we only
assessed CRP. It is possible that other biomarkers,
namely procalcitonin, might have different results.
Conclusions
In conclusion, in severe CAS, daily CRP measurement
during the first five ICU days after antibiotic prescription
was useful in the identification, as early as D3, of patients
with poor outcome. The rate of CRP decrease, assessed by
the CRP-ratio course, was markedly associated with clini-
cal course and prognosis. In addition, the identification of
the pattern of CRP-ratio response to antibiotic therapy
was useful in the recognition of the individual clinical evo-
lution of CAS patients, improving or worsening, as well as,
of the rate of improvement. With the present data, as well
as from previously published papers assessing CRP moni-
toring, we think it is time to safely design a trial to assess
the impact of the CRP-guided antibiotic therapy approach,
not only to shorten antibiotic therapy but also to identify
earlier patients not responding to treatment.
Key messages
￿ In this large multicenter prospective observational
study, we showed that daily CRP measurement after
antibiotic prescription was useful, as early as Day 3,
in discriminating community-acquired sepsis
patients with good and bad outcome.
￿ The rate of CRP decrease, assessed by the CRP-
ratio course, was markedly associated with clinical
course and prognosis; a patient with an average
decrease of the CRP of 10% per day has 32% more
chances of surviving.
￿ We identified three patterns of CRP-ratio response
to antibiotics, fast response, slow response and no
response, with a marked correlation with ICU and
hospital mortality.
￿ The identification of CRP-ratio pattern of response
to antibiotics was useful in the recognition of the
Figure 4 SOFA score course during the first five ICU days according to CRP-ratio patterns. Mean SOFA score for the first five days in ICU
stay, according to the patterns of CRP-ratio response to antibiotics: fast response, slow response and no response. Error bars represent point-
wise 95% confidence intervals. CRP, C-reactive protein; ICU; intensive care unit; SOFA, Sequential Organ Failure Assessment.
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sis patients, improving or worsening, as well as, of the
rate of improvement; a patient with a no response
pattern has 3.0 times more chances of dying in the
ICU in comparison with a patient with fast response.
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